One Equity Partners, the private equity unit of JP Morgan, has announced an offer to buy the wound care business of a Johnson & Johnson company for an undisclosed amount, though private equity firms showed less interest in healthcare buyouts in the first half of this year than in the past two years.

This would be the second such deal in the last two months where a private equity firm has agreed to buy the wound care business of a large healthcare company, after Bristol-Myers Squibb chose to sell ConvaTec to Avista Capital Partners and Nordic Capital for $4.1bn.